Top Section/Ad
Top Section/Ad
Most recent
A slow destruction of misallocated investment is more likely than a sudden stop
LBO financing includes $5.75bn term loan to be priced early next week
Investors eye 2028, 2031, 2032 as big years for loan maturities
Even leveraged deals still being underwritten, though banks are selective
More articles/Ad
More articles/Ad
More articles
-
Pantheon Healthcare, the pharmaceutical developer owned by Permira, is marketing a €300m loan to finance the acquisition of Telematic and Biomedical Services with bankers saying demand for leveraged loans shows no signs of abating. -
Hong Kong-listed China Shengmu Organic Milk is set to make a comeback to the loans market about a year and a half after its last visit, as lenders remain wary about the company’s industry.
-
China Aircraft Leasing Group Holdings (CALC), which made its offshore loan market debut last year, is back for a $175m aircraft pre-delivery financing.
-
Indian banks are muscling into offshore loan syndications they previously rejected out of hand, driven by a desperate need to lend amid a slowdown in domestic borrowing. Shruti Chaturvedi reports.
-
The European leveraged finance markets are licking their lips in anticipation of a new €2.5bn deal backing Bain and Cinven’s takeover of Stada Arzneimittel, the German generic drug manufacturer.
-
Corporate issuers of triple-C rated bonds have finally found a reason to enter the primary market, as investor expectation over the chances of the European Central Bank raising rates has opened a window for them in July.
